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Editorial
This is the time of year when pumpkins are in season, and
are incorporated into traditional festivals in Europe and
North America (Harvest, Halloween, Thanksgiving). If you
have previously considered pumpkins as good only for
carving into grinning Jack O’Lanterns then the short review
from Yadev et al. (1) might shed a little light on some of its
potential medicinal properties, including antioxidant, antiinflammatory, anti-carcinogenic and anti-diabetic. However,
the active compounds, possibly various alkaloids and
flavonoids, have yet to be isolated and characterised, and
much of the work cited has been done in animal or in vitro
models, so the beneficial effects need to be confirmed in
human subjects before pumpkin can graduate from
traditional herbal remedy to new, safe, effective therapeutic
agent. Pumpkin, along with its fruit and vegetable
colleagues, has been linked with reduced risk of
oesophageal adenocarcinoma and its precursor, Barratt’s
oesophagus; this relationship is explored by Kubo et al. in
their review(2). The epidemiological evidence is apparently
strongest for a protective effect of vitamin C, b-carotene,
raw fruit and dark green, leafy and cruciferous vegetables,
carbohydrates, fibre, Fe and possibly folate, while red meat
and processed foods are associated with increased risk. Red
and processed meats have long been dietary suspects in
breast cancer carcinogenesis, though the evidence has been
controversial, prompting Alexander et al. to conduct a
review and meta-analysis(3) of all available prospective
cohort studies, incorporating over 25 000 cases of breast
cancer. The consensus the authors arrive at is that there is no
strong independent association between intake of red meat
or processed meat and breast cancer, though they note that
results were sensitive to the choice of model (fixed or
random effects). Hypotheses concerning the possible role of
diet early in life need further (very long-term!) prospective
studies, while investigation of the (conflicting) evidence
from studies suggesting that meat intake could affect cancer
risk through tumour hormone receptor status, whether
positive or negative, is also required before unequivocal
conclusions can be drawn.
Arguably, according to popular perceptions, the main
contender for dietary public enemy number one is fat.
Nevertheless, fats form a significant component of most
Western diets, and helping individuals choose a diet
containing the correct balance of fats to help reduce
mortality due to CVD is a challenge here taken up by Bester
et al. (4), who compare the cardiovascular effects of four
edible oils. In addition to the widely known cholesterollowering effects of olive oil and sunflower-seed oil, fish oil
has been shown to reduce cardiac arrhythmias (in rats – the
evidence from human studies is mixed), together with
having some beneficial effects on serum lipids. Recently, it
has been reported (also in rats) that red palm oil may be

beneficial in the recovery of the heart from ischaemia–
reperfusion injury; in addition, this oil has a neutral or
positive effect on the serum lipid profile (in contrast with the
belief, unfounded as it turns out, that this oil would have a
detrimental effect on blood lipids due to its relatively high
saturated fat content). Obesity is a major risk factor for
CVD, and the review by Hariri & Thibault(5) explores how
the amount and type of dietary fat can affect weight gain,
body composition and adipose tissue cellularity in animal
models (and humans). The picture emerging shows that
high-fat diets promote overconsumption of energy due to
their high palatability and low satiating effects, while
resistance to high circulating levels of leptin and insulin
together with lowered suppression of ghrelin also promote
hyperphagia. Adiposity is promoted by the low energy costs
of storing dietary fat in adipose tissue, but all fats are not
equal – saturated fat may be more readily stored (especially
the longer-chain fatty acids) and less thermogenic than
mono- or polyunsaturated fats; the latter may also be more
satiating. Other contributing factors discussed include
genetics, sex, feeding patterns, social factors, stress and
the reversibility of obesity (often unsuccessful in animals
as in humans, even on a low-fat diet when this is provided
ad libitum).
In humans, a major risk factor for cardiometabolic
disease is abdominal obesity, which can be defined in terms
of waist circumference. However, deciding on the optimal
cut-off value to be used in population screening is a
problem, since there are variations among different ethnic
groups (as suggested by the observation that Europeans need
a higher cut-off than Asians to obtain the same prevalence
of diabetes) and regionally within an ethnic group. Wang
et al. (6) express concern that the approach used by most
workers in the field is over-simplified, since the cut-offs
used invariably correlate with population waist circumference levels, meaning that the true extent of the prevalence of
‘abdominal obesity’ is masked in populations with higher
waist circumferences because a higher cut-off is being
applied than in populations with a lower waist circumference. If genetic differences are responsible for regional
differences in waist circumference, then region-specific
cut-offs would be appropriate, whereas if the variation
between regions is due to differences in lifestyle then a
uniform cut-off across regions is preferable; these authors
suggest that calculating the absolute risk corresponding with
increasing waist circumference cut-off values in different
regions would clarify the issue and help to identify the
cut-off value above which action should be taken. Browning
et al. take the debate further in their systematic review(7)
of the usefulness of waist-to-height ratio as a screening tool
for the prediction of CVD, diabetes and related diseases.
Taking height into account prevents over-evaluating the
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risk for tall individuals who have the same waist
circumference as short individuals, and potentially offers
the advantage that a single cut-off could be applied in
different populations, including both sexes and across all
ages. On balance, the data from the seventy-eight studies
considered show that waist circumference and waistto-height ratio are stronger predictors of disease risk than
BMI, though a supporting meta-analysis would be required
to confirm this. For the sake of simplicity, these authors
argue in favour of adopting a boundary value of 0.5 for
waist-to-height ratio above which there is increased
disease risk for all adults, pointing out that this can be
presented as a straightforward public health message
‘keep your waist circumference to less than half your
height’, and which can be measured easily without the
need for weighing equipment. The remaining challenge for
future studies is to identify the clinically relevant boundary
value for children.
Diet is a key component in the prevention and treatment
of obesity, and finding a food that is protective would be
highly beneficial. Ready-to-eat cereals (RTEC) could
represent such a food, being associated with lower BMI in
many reports; but the question as to whether it is just the
whole-grain versions that are good for you (and not those
made from refined cereals) needs to be addressed, and is
here tackled by Kosti et al. (8), who review the evidence on
the health benefits of RTEC, both refined and unrefined.
Perhaps surprisingly, eating even sweetened, low-fibre
‘children’s cereals’ is associated with lower adiposity in
children and adolescents, while other studies have shown
that it is high-fibre wholegrain cereals that are best for
weight control among adults. Notwithstanding specific
effects of the cereals themselves, it is possible that their
consumption may simply be a marker for a generally
healthier lifestyle (less snacking, more exercise), while at
the same time they replace higher-fat/high-sugar foods in
the diet such as meat/eggs, sweets/soda. Furthermore, RTEC
are often fortified with micronutrients (Fe, thiamin,
riboflavin, niacin, folic acid, and vitamins B6, B12 and D)
and are usually consumed with milk, which contains useful
nutrients such as Ca and may confer additional anti-obesity
benefits. Further work is needed to distinguish the effects of
the various wholegrain v. refined RTEC, but in the meantime
dietary advice should probably focus on promoting intake of
the more nutrient-dense, high-fibre, low-sugar versions for
obesity prevention, with food labelling to help the consumer
choose. Cereals that have been specially processed can
perform a therapeutic role by stimulating secretion of
antisecretory factor, and Ulgheri et al. (9) describe how this
could be useful in the treatment of inflammatory bowel
disease, gastroenteritis and Ménière’s disease. Post-weaning
diarrhoea in piglets can also be counteracted by this means,
reducing the requirement for antibiotics.
Bacterial fermentation of fibre in the caecum and colon
generates SCFA, including butyrate, which are responsible
for some of the beneficial effects (including anticancer)
conferred by dietary fibre, discussed here by Guilloteau
et al. (10). Butyrate is the preferred metabolic fuel of
colonocytes and is essential for the health of the colon; thus
the finding that resistant starch is the most butyrogenic
substrate is important in the context of preventing certain

digestive diseases such as diverticulosis. Butyrate reaching
the liver affects glucose metabolism and could help prevent
insulin resistance; it may also affect energy balance via the
hypothalamus. Early postnatal development of the gastrointestinal tract is also controlled by butyrate, and it can be
given as a feed additive, especially to young animals, to
optimise nutrient digestibility, feed efficiency, growth rate
and adiposity, as well as to control gut pathogens; these
authors recommend the investigation of similar potential
benefits of supplementary butyrate in human infants. A
substance certainly not beneficial to infants is acrylamide, a
toxic (mutagenic, genotoxic, carcinogenic, neurotoxic)
contaminant detectable in infant formulae and commercial
baby foods. It is generated in starchy foods prepared by
baking, frying or microwaving, and is also present in
purified drinking water in which it is used as a flocculating
agent. Children probably consume two or three times the
amount that adults do when expressed per unit body weight,
and thus need to be protected from high exposure. Based on
their investigations, Erkekoğlu & Baydar(11) recommend
that manufacturers must follow good manufacturing
practices to minimise levels of this (and other) contaminants, while routine testing and strict law enforcement are
also necessary. Parents can also reduce children’s exposure
to acrylamide by avoiding giving them fried and fatty foods,
concentrating instead on boiled and raw foods, including
plenty of fruit and vegetables.
At the other end of the life-course, age-related cognitive
decline is the focus of the review by Macready et al. (12)
which examines the evidence provided by randomised
controlled trials for the effects of diet on cognition. A major
difficulty in interpreting the results of these trials is the
disparities among the cognitive domains being explored and
the tests used; so these authors attempt to identify the
domains (for example, episodic memory) and tasks (for
example, common objects recall) most sensitive to chronic
supplementation, to facilitate researchers in their study
design. Frustratingly, though a few nutrients (for example,
flavonoids, B vitamins) show some promise, methodological shortcomings (for example, using cognitive tests that
were not sufficiently sensitive, inadequate statistics) make
firm conclusions impossible in many cases. Thus these
authors suggest that a more consistent approach is required
for future chronic dietary studies, using standardised,
sensitive, appropriate and discriminatory cognitive tasks
and suitable statistical treatment, so that the public can be
given accurate dietary advice.
Finally, this is my last Editorial as Editor-in-Chief of
Nutrition Research Reviews, and I would like to welcome
Graham Burdge to the role – I hope he enjoys it as much
as I have!
K.M. Younger
Editor-in-Chief
School of Biological Sciences
Dublin Institute of Technology
Kevin Street
Dublin 8
Republic of Ireland
Katherine.Younger@dit.ie
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